DSM-Firmenich AG

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: CH1216478797
EUR
68.18
0.18 (0.26%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-summaryPrice Point
High/Low

1Day

52 Week

Valuation
Technical
Day's Volume

CASH

519.64 k

Shareholding (Dec 2023)

FII

0.31%

Held by 3 FIIs

DII

99.69%

Held by 0 DIIs

Promoter

0.00%

iScoreScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Dashboard
1

Poor Management Efficiency with a low ROE of 2.20%

  • The company has been able to generate a Return on Equity (avg) of 2.20% signifying low profitability per unit of shareholders funds
2

With ROE of 3.23%, it has a Very Expensive valuation with a 0.93 Price to Book Value

3

Below par performance in long term as well as near term

stock-summaryMojo Parameters
Mojo Parameters
Stock DNA
stock-summary
Industry

Pharmaceuticals & Biotechnology

stock-summary
Market cap

EUR 18,613 Million ()

stock-summary
P/E

29.00

stock-summary
Industry P/E

NA

stock-summary
Dividend Yield

0.00%

stock-summary
Debt Equity

0.12

stock-summary
Return on Equity

3.23%

stock-summary
Price to Book

0.87

Revenue and Profits:
Net Sales:
(Quarterly Results - )
Net Profit:
stock-summaryTotal Returns
Total Returns (Price + Dividend) stock-summary
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
-15.28%
0%
-15.28%
6 Months
-29.16%
0%
-29.16%
1 Year
-33.87%
0%
-33.87%
2 Years
-21.06%
0%
-21.06%
3 Years
0%
0%
0.0%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%

DSM-Firmenich AG for the last several years.

Risk Adjusted Returns v/s stock-summary
stock-summaryNews & Corporate Actions
News
Icon
No Recent News for the Company
Announcements stock-summary
Icon
No announcement available
Corporate Actions stock-summary
Icon
No corporate action available
stock-summaryKey Factors
Quality key factors stock-summary
Factor
Value
Sales Growth (5y)
29.55%
EBIT Growth (5y)
13.75%
EBIT to Interest (avg)
7.05
Debt to EBITDA (avg)
0.84
Net Debt to Equity (avg)
0.09
Sales to Capital Employed (avg)
0.37
Tax Ratio
34.43%
Dividend Payout Ratio
264.61%
Pledged Shares
0
Institutional Holding
0.26%
ROCE (avg)
3.39%
ROE (avg)
2.20%
Valuation key factors
Factor
Value
P/E Ratio
29
Industry P/E
Price to Book Value
0.93
EV to EBIT
20.53
EV to EBITDA
10.25
EV to Capital Employed
0.94
EV to Sales
1.73
PEG Ratio
0.14
Dividend Yield
NA
ROCE (Latest)
4.58%
ROE (Latest)
3.23%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Mildly Bullish
RSI
No Signal
Bullish
Bollinger Bands
Bearish
Bearish
Moving Averages
Bearish (Daily)
KST
Bearish
Dow Theory
Bearish
Bearish
OBV
Mildly Bearish
No Trend
stock-summary Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
stock-summaryShareholding
Shareholding Snapshot : Dec 2023stock-summary
Shareholding Compare (%holding) stock-summary
Majority shareholders

Foreign Institutions

Domestic Funds

Held in 0 Schemes (0%)

Foreign Institutions

Held by 3 Foreign Institutions (0.31%)

Strategic Entities with highest holding

Highest Public shareholder

stock-summaryFinancial
[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "alert": "No Quarterly Results declared by DSM-Firmenich AG"
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'23",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2023 is 26.66% vs -26.69% in Dec 2022",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2023 is -233.89% vs -46.02% in Dec 2022",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'23",
        "Dec'22",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "10,627.00",
          "val2": "8,390.00",
          "chgp": "26.66%",
          "chgp_class": "positive"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "1,314.00",
          "val2": "1,377.00",
          "chgp": "-4.58%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "162.00",
          "val2": "67.00",
          "chgp": "141.79%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-514.00",
          "val2": "-65.00",
          "chgp": "-690.77%",
          "chgp_class": "negative"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "-636.00",
          "val2": "475.00",
          "chgp": "-233.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "0.70%",
          "val2": "86.40%",
          "chgp": "-8.57%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]
Annual Results Snapshot (Consolidated) - Dec'23stock-summary
Dec'23
Dec'22
Change(%)
Net Sales
10,627.00
8,390.00
26.66%
Operating Profit (PBDIT) excl Other Income
1,314.00
1,377.00
-4.58%
Interest
162.00
67.00
141.79%
Exceptional Items
-514.00
-65.00
-690.77%
Consolidate Net Profit
-636.00
475.00
-233.89%
Operating Profit Margin (Excl OI)
0.70%
86.40%
-8.57%
USD in Million.
Direction Arrows
Net Sales

YoY Growth in year ended Dec 2023 is 26.66% vs -26.69% in Dec 2022

Direction Arrows
Consolidated Net Profit

YoY Growth in year ended Dec 2023 is -233.89% vs -46.02% in Dec 2022

stock-summaryCompany CV
About DSM-Firmenich AG stock-summary
stock-summary
DSM-Firmenich AG
Pharmaceuticals & Biotechnology
No Details Available.
Company Coordinates stock-summary
Icon
No Company Details Available